Hi Supertramp...You are correct...from the article today"...Ong already has a $12.60-a-share discounted cash flow valuation on Progen but says this is conservative should teh trial result be positive."regardsDF
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025